Ischaemia-modified albumin predicts the outcome of cardiopulmonary resuscitation: An experimental study

Resuscitation

Volumn 81, Issue 5, 2010, Pages 591-595

  Xanthos, Theodoros ^a   Iacovidou, Nicoletta ^a   Pantazopoulos, Ioannis ^a   Vlachos, Ioannis ^a   Bassiakou, Eleni ^a   Stroumpoulis, Konstantinos ^a   Kouskouni, Evagelia ^b   Karabinis, Andreas ^c   Papadimitriou, Lila ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

Author keywords

Albumin cobalt binding test; Cardiac arrest; CPP; CPR; Ischaemia modified albumin; Swine

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEFIBRILLATION; EXPERIMENTAL STUDY; HEART ARREST; HEART VENTRICLE FIBRILLATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESUSCITATION; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOLOGICAL MARKERS; CARDIOPULMONARY RESUSCITATION; CORONARY CIRCULATION; DISEASE MODELS, ANIMAL; ELECTRIC COUNTERSHOCK; HEART ARREST; ISCHEMIA; MALE; PROGNOSIS; RESPIRATION, ARTIFICIAL; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; SWINE; VENTRICULAR FIBRILLATION;

EID: 77951653110     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2010.01.010     Document Type: Article

References (30)

1. Pantazopoulos I., Papadimitriou L., Dontas I., Demestiha T., Iakovidou N., Xanthos T. Ischaemia modified albumin in the diagnosis of acute coronary syndromes. Resuscitation 2009, 80:306-310.
2. Worster A., Devereaux P.J., Heels-Ansdell D., et al. Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 2005, 172:1685-1690.
3. Koudouna E., Xanthos T., Bassiakou E., et al. Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Acta Anaesthesiol Scand 2007, 51:1123-1129.
4. Roy D., Quilesa J., Aldamaa G., et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004, 97:297-301.
5. Bar-Or D., Curtis G., Rao N., Bampos N., Lau E. Characterization of the Co(2q) and Ni(2q) binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001, 268:42-47.
6. Xanthos T., Lelovas P., Vlachos I., et al. Cardiopulmonary arrest and resuscitation in Landrace/Large White swine: a research model. Lab Anim 2007, 41:353-362.
7. van Alem A.P., Vrenken R.H., de Vos R., Tijssen J.G., Koster R.W. Use of automated external defibrillator by first responders in out-of-hospital cardiac arrest: prospective controlled trial. BMJ 2003, 327:1312-1317.
8. Iacovidou N., Briana D.D., Boutsikou M., et al. Cord blood ischemia-modified albumin levels in normal and intrauterine growth restricted pregnancies. Mediat Inflamm 2008, 2008:523081.
9. Hoffman J.I. Maximal coronary flow and the concept of coronary vascular reserve. Circulation 1984, 70:153-159.
10. Klocke F.J., Ellis A.K. Control of coronary blood flow. Annu Rev Med 1980, 31:489-508.
11. Ditchey R.V., Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation 1988, 78:382-389.
12. Luqman N., Sung R.J., Wang C.L., Kuo C.T. Myocardial ischemia and ventricular fibrillation: pathophysiology and clinical implications. Int J Cardiol 2007, 119:283-290.
13. Morrow D.A., De Lemos J.A., Sabatine M.S., Antman E.M. The search for a biomarker of cardiac ischemia. Clin Chem 2003, 49:537-539.
14. Anwaruddin S., Januzzi J.L., Baggish A.L., Lewandrowski E.L., Lewandrowski K.B. Ischemia modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005, 123:140-145.
15. Sanders A.B., Ogle M., Ewy G.A. Coronary perfusion pressure during cardiopulmonary resuscitation. Am J Emerg Med 1985, 3:11-14.
16. Ralston S.H., Voorhees W.D., Babbs C.F. Intrapulmonary epinephrine during prolonged cardiopulmonary resuscitation: improved regional blood flow and resuscitation in dogs. Ann Emerg Med 1984, 13:79-86.
17. Michael J.R., Guerci A.D., Koehler R.C., et al. Mechanism by which epinephrine augments cerebral and myocardial perfusion during cardiopulmonary resuscitation in dogs. Circulation 1984, 69:822-835.
18. Neimann J.T., Rosborough J.P., Niskanen R.A., Alferness C., Criley J.M. Mechanical " cough" cardiopulmonary resuscitation during cardiac arrest in dogs. Am J Cardiol 1985, 55:199-204.
19. Feneley M.P., Maier G.W., Kern K.B., et al. Influence of compression rate on initial success of resuscitation and 24-hour survival after prolonged manual cardiopulmonary resuscitation in dogs. Circulation 1988, 77:240-250.
20. Kern K.B., Sanders A.B., Badylak S.F., et al. Long-term survival with open-chest cardiac massage after ineffective closed-chest compressions in a canine model. Circulation 1987, 75:498-503.
21. Roy D., Quiles J., Sinha M., Aldama G., Gaze D., Kaski J.C. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 2004, 93:366-368.
22. Turedi S., Gunduz A., Mentese A., et al. Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation. Resuscitation 2009, 80:994-999.
23. Kumar A., Sivakanesan R., Gunasekera S. Ischemia modified albumin: a potent marker in acute myocardial infarction in normolipidaemic. Pak J Med Sci 2008, 24:364-367.
24. Carreiro-Lewandowski E. Update on cardiac biomarkers. Lab Med 2006, 37:598-605.
25. Apple F.S., Wu A.H., Mair J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005, 51:810-824.
26. Lippi G., Montagnana M., Salvagno G.L., Guidi G.C. The measurement of ischemia modified albumin in clinical laboratories: where do we stand?. J Clin Ligand Assay 2005, 28:207-215.
27. Predki P.F., Harford C., Brar P., Sarkar B. Further characterization of the N-terminal copper(II)- and nickel(II)-binding motif of proteins. Studies of metal binding to chicken serum albumin and the native sequence peptide. Biochem J 1992, 287:211-215.
28. Gunduz A., Turkmen S., Turedi S., et al. Time-dependent variations in ischemia-modified albumin levels in mesenteric ischemia. Acad Emerg Med 2009, 16:539-543.
29. Apple F.S., Quist H.E., Otto A.P., Mathews W.E., Murakami M.M. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 2002, 48:1097-1100.
30. Bar-Or D., Rael L.T., Bar-Or R., et al. The cobalt-albumin binding assay: insights into its mode of action. Clin Chim Acta 2008, 387:120-127.